Paclitaxel-coated balloons in peripheral artery disease: how much is enough?

被引：3
|
作者：
Liistro, Francesco [1 ]
Di Mario, Carlo [2 ]
机构：
[1] Osped San Donato, Arezzo, Italy
[2] Univ Hosp Careggi, Largo G Alessandro Brambilla 3, I-50134 Florence, Italy
来源：
EUROPEAN HEART JOURNAL | 2020年 / 41卷 / 27期
关键词：
FEMOROPOPLITEAL; TRIAL; STENT;
D O I：
10.1093/eurheartj/ehaa239
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2553 / 2555
页数：3
相关论文
共 50 条
  • [21] Paclitaxel-coated balloons: Are all created equal?
    Alfonso, Fernando
    Del Val, David
    Cortese, Bernardo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 322 : 101 - 102
  • [22] Novel Strategies to Reduce Femoropopliteal Restenosis Low-Dose Paclitaxel-Coated Balloons and Paclitaxel-Coated Balloons Plus Stenting
    Goldsweig, Andrew M.
    Aronow, Herbert D.
    CIRCULATION, 2017, 135 (23) : 2237 - 2240
  • [23] Paclitaxel-coated balloons and stents for the treatment of peripheral artery disease: proceedings from the Cardiovascular Research Technologies (CRT) 2019 Town Hall
    Dan, Kazuhiro
    Garcia-Garcia, Hector M.
    Hideo-Kajita, Alexandre
    Zhang, Cheng
    Wermers, Jason P.
    Kolm, Paul
    Torguson, Rebecca
    Waksman, Ron
    EUROINTERVENTION, 2019, 15 (04) : E317 - E319
  • [24] Paclitaxel-coated peripheral artery devices are not associated with increased mortality
    Kumins, Norman H.
    King, Alexander H.
    Ambani, Ravi N.
    Thomas, Jones P.
    Bose, Saideep
    Shishehbor, Mehdi H.
    Li, Jun
    Wong, Virginia L.
    Harth, Karem C.
    Cho, Jae S.
    Kashyap, Vikram S.
    JOURNAL OF VASCULAR SURGERY, 2020, 72 (03) : 968 - 976
  • [25] Mortality risk after use of a paclitaxel-coated stent in femoropopliteal peripheral artery disease
    Tan, Michinao
    Urasawa, Kazushi
    Haraguchi, Takuya
    Ando, Hiroshi
    Tsubakimoto, Yoshinori
    Kamoi, Daisuke
    Habara, Maoto
    Nakama, Tatsuya
    Sakamoto, Hiroshi
    Kimura, Masayoshi
    Doijiri, Tatsuki
    Sugihara, Makoto
    Imoto, Yuki
    Sato, Tomoyasu
    Hayashi, Taichi
    Sato, Yusuke
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2022, 37 (01) : 136 - 144
  • [26] Mortality risk after use of a paclitaxel-coated stent in femoropopliteal peripheral artery disease
    Michinao Tan
    Kazushi Urasawa
    Takuya Haraguchi
    Hiroshi Ando
    Yoshinori Tsubakimoto
    Daisuke Kamoi
    Maoto Habara
    Tatsuya Nakama
    Hiroshi Sakamoto
    Masayoshi Kimura
    Tatsuki Doijiri
    Makoto Sugihara
    Yuki Imoto
    Tomoyasu Sato
    Taichi Hayashi
    Yusuke Sato
    Cardiovascular Intervention and Therapeutics, 2022, 37 : 136 - 144
  • [27] Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
    Rosenfield, Kenneth
    Jaff, Michael R.
    White, Christopher J.
    Rocha-Singh, Krishna
    Mena-Hurtado, Carlos
    Metzger, D. Christopher
    Brodmann, Marianne
    Pilger, Ernst
    Zeller, Thomas
    Krishnan, Prakash
    Gammon, Roger
    Mueller-Huelsbeck, Stefan
    Nehler, Mark R.
    Benenati, James F.
    Scheinert, Dierk
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02): : 145 - 153
  • [28] A Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease REPLY
    Rosenfield, Kenneth
    Metzger, D. Christopher
    Scheinert, Dierk
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18): : 1785 - 1786
  • [29] REPLY: Sirolimus- vs Paclitaxel-Coated Balloons
    Serruys, Patrick W.
    Ninomiya, Kai
    Onuma, Yoshinobu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (04)
  • [30] Paclitaxel-coated balloons are safe for the treatment of arterial stenoses
    Rissanen, Tuomas
    LANCET, 2023, 402 (10415): : 1808 - 1809
12345